本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

14.70
+0.48003.38%
盘后14.700.00000.00%18:45 EDT
成交量:179.44万
成交额:2,678.78万
市值:21.36亿
市盈率:-5.50
高:15.36
开:14.41
低:14.36
收:14.22
数据加载中...
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities